These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 28490132

  • 41. Interaction of native Bowman-Birk soybean protease inhibitor and its hydrophobized derivative with multilamellar vesicles of soybean phospholipids.
    Balkina AS, Selischeva AA, Sorokoumova GM, Larionova NI.
    Biochemistry (Mosc); 2006 Jan; 71(1):84-9. PubMed ID: 16457624
    [Abstract] [Full Text] [Related]

  • 42. An advance for removing antinutritional protease inhibitors: Soybean whey purification of Bowman-Birk chymotrypsin inhibitor by combination of two oppositely charged polysaccharides.
    Li X, Hua Y, Chen Y, Kong X, Zhang C, Yu X.
    Carbohydr Polym; 2017 May 15; 164():349-357. PubMed ID: 28325335
    [Abstract] [Full Text] [Related]

  • 43. Kinetic and mechanistic study of ultrasonic inactivation of Kunitz (KTI) and Bowman-Birk (BBI) inhibitors in relation to process-relevant parameters.
    Wu Y, Li W, Colombo E, Martin GJO, Ashokkumar M.
    Food Chem; 2023 Feb 01; 401():134129. PubMed ID: 36099821
    [Abstract] [Full Text] [Related]

  • 44. Bowman-Birk Inhibitor Mutants of Soybean Generated by CRISPR-Cas9 Reveal Drastic Reductions in Trypsin and Chymotrypsin Inhibitor Activities.
    Kim WS, Gillman JD, Kim S, Liu J, Janga MR, Stupar RM, Krishnan HB.
    Int J Mol Sci; 2024 May 21; 25(11):. PubMed ID: 38891766
    [Abstract] [Full Text] [Related]

  • 45. Anti-carcinogenic soyabean Bowman-Birk inhibitors survive faecal fermentation in their active form and do not affect the microbiota composition in vitro.
    Marín-Manzano MC, Ruiz R, Jiménez E, Rubio LA, Clemente A.
    Br J Nutr; 2009 Apr 21; 101(7):967-71. PubMed ID: 19353764
    [Abstract] [Full Text] [Related]

  • 46. Prediction of the secondary structure of Bowman-Birk soybean protease inhibitor from LTS sequence.
    Ventura MM.
    An Acad Bras Cienc; 1985 Sep 21; 57(3):359-67. PubMed ID: 3832979
    [Abstract] [Full Text] [Related]

  • 47. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR.
    Am J Clin Nutr; 1998 Dec 21; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [Abstract] [Full Text] [Related]

  • 48. Targeted inactivation of soybean proteinase inhibitors using zinc.
    Rehder A, Sørensen JC, Markedal KE, Sørensen H, Sørensen S, Petersen IL.
    Food Chem; 2021 Jul 01; 349():129049. PubMed ID: 33581435
    [Abstract] [Full Text] [Related]

  • 49. Interaction between duodenase, a proteinase with dual specificity, and soybean inhibitors of Bowman-Birk and Kunitz type.
    Gladysheva IP, Zamolodchikova TS, Sokolova EA, Larionova NI.
    Biochemistry (Mosc); 1999 Nov 01; 64(11):1244-9. PubMed ID: 10611528
    [Abstract] [Full Text] [Related]

  • 50. Nutritional and health benefits of soy proteins.
    Friedman M, Brandon DL.
    J Agric Food Chem; 2001 Mar 01; 49(3):1069-86. PubMed ID: 11312815
    [Abstract] [Full Text] [Related]

  • 51. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH, Wan XS, Rubin H, Schechter NM, Kennedy AR.
    Arch Biochem Biophys; 1997 Aug 01; 344(1):133-8. PubMed ID: 9244390
    [Abstract] [Full Text] [Related]

  • 52. Inhibition of matrix metalloproteinase-1 activity by the soybean Bowman-Birk inhibitor.
    Losso JN, Munene CN, Bansode RR, Bawadi HA.
    Biotechnol Lett; 2004 Jun 01; 26(11):901-5. PubMed ID: 15269538
    [Abstract] [Full Text] [Related]

  • 53. Ultrastructural localization of Bowman-Birk inhibitor on thin sections of Glycine max (soybean) cv. Maple Arrow by the gold method.
    Horisberger M, Tacchini-Vonlanthen M.
    Histochemistry; 1983 Jun 01; 77(3):313-21. PubMed ID: 6305885
    [Abstract] [Full Text] [Related]

  • 54. Monoclonal antibodies against soybean Bowman-Birk inhibitor recognize the protease-reactive loops.
    Mao Y, Lai C, Vogtentanz G, Schmidt B, Day T, Miller J, Brandon DL, Chen D.
    Protein J; 2005 Jul 01; 24(5):275-82. PubMed ID: 16284725
    [Abstract] [Full Text] [Related]

  • 55. Crystal structure of a 16 kDa double-headed Bowman-Birk trypsin inhibitor from barley seeds at 1.9 A resolution.
    Song HK, Kim YS, Yang JK, Moon J, Lee JY, Suh SW.
    J Mol Biol; 1999 Nov 12; 293(5):1133-44. PubMed ID: 10547291
    [Abstract] [Full Text] [Related]

  • 56. Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents.
    Clemente A, Arques Mdel C.
    World J Gastroenterol; 2014 Aug 14; 20(30):10305-15. PubMed ID: 25132747
    [Abstract] [Full Text] [Related]

  • 57. Soybean Bowman-Birk protease inhibitor (BBI): identification of the mechanisms of BBI suppressive effect on growth of two adenocarcinoma cell lines: AGS and HT29.
    Fereidunian A, Sadeghalvad M, Oscoie MO, Mostafaie A.
    Arch Med Res; 2014 Aug 14; 45(6):455-61. PubMed ID: 25014623
    [Abstract] [Full Text] [Related]

  • 58. In vitro digestibility of the cancer-preventive soy peptides lunasin and BBI.
    Park JH, Jeong HJ, Lumen BO.
    J Agric Food Chem; 2007 Dec 26; 55(26):10703-6. PubMed ID: 18038984
    [Abstract] [Full Text] [Related]

  • 59. A Bowman-Birk protease inhibitor purified, cloned, sequenced and characterized from the seeds of Maclura pomifera (Raf.) Schneid.
    Indarte M, Lazza CM, Assis D, Caffini NO, Juliano MA, Avilés FX, Daura X, López LM, Trejo SA.
    Planta; 2017 Feb 26; 245(2):343-353. PubMed ID: 27778107
    [Abstract] [Full Text] [Related]

  • 60. Study on interaction between duodenase protease with dual specificity and inhibitors of bowman-birk family.
    Gladysheva IP, Popykina NA, Zamolodchikova TS, Larionova NI.
    Protein Pept Lett; 2002 Apr 26; 9(2):139-44. PubMed ID: 12141911
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.